TuisTMCI • NASDAQ
add
Treace Medical Concepts Inc
Vorige sluiting
$7,30
Dagwisseling
$7,25 - $8,46
Jaarwisseling
$3,92 - $15,98
Markkapitalisasie
510,84 m USD
Gemiddelde volume
281,15 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 45,09 m | 10,62% |
Bedryfskoste | 51,27 m | 1,36% |
Netto inkomste | -15,36 m | 12,33% |
Netto winsgrens | -34,07 | 20,75% |
Wins per aandeel | -0,25 | 10,71% |
EBITDA | -12,98 m | 20,16% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 82,80 m | -32,22% |
Totale bates | 212,92 m | -11,41% |
Totale aanspreeklikheid | 108,02 m | 5,38% |
Totale ekwiteit | 104,91 m | — |
Uitstaande aandele | 62,30 m | — |
Prys om te bespreek | 4,35 | — |
Opbrengs op bates | -17,24% | — |
Opbrengs op kapitaal | -21,19% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -15,36 m | 12,33% |
Kontant van bedrywe | -11,84 m | -24,48% |
Kontant van beleggings | 5,76 m | 25,36% |
Kontant van finansiering | 8,00 k | -94,97% |
Netto kontantverandering | -6,07 m | -27,62% |
Beskikbare kontantvloei | -7,50 m | 37,82% |
Meer oor
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Gestig
2014
Webwerf
Werknemers
516
